litlas
Log inCreate account

Christopher P. Day

Active 1990–2024

128
Papers
48,831
Citations
103
h-index
128
i10-index

Citations

Citations per year for Christopher P. Day1978: 1 citations1991: 1 citations1992: 9 citations1993: 10 citations1994: 38 citations1995: 25 citations1996: 26 citations1997: 28 citations1998: 52 citations1999: 72 citations2000: 104 citations2001: 136 citations2002: 176 citations2003: 171 citations2004: 178 citations2005: 208 citations2006: 205 citations2007: 215 citations2008: 288 citations2009: 285 citations2010: 398 citations2011: 412 citations2012: 424 citations2013: 563 citations2014: 582 citations2015: 690 citations2016: 686 citations2017: 633 citations2018: 543 citations2019: 1,761 citations2020: 1,988 citations2021: 2,050 citations2022: 1,605 citations2023: 1,132 citations2024: 1,709 citations2025: 788 citations2026: 26 citations1979–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,128 citing papers, 21.2% of this breakdownChina: 2,477 citing papers, 12.7% of this breakdownUnited Kingdom: 1,488 citing papers, 7.6% of this breakdownItaly: 1,265 citing papers, 6.5% of this breakdownGermany: 858 citing papers, 4.4% of this breakdownJapan: 719 citing papers, 3.7% of this breakdownSpain: 640 citing papers, 3.3% of this breakdownFrance: 625 citing papers, 3.2% of this breakdownSouth Korea: 577 citing papers, 3% of this breakdownAustralia: 487 citing papers, 2.5% of this breakdownCanada: 451 citing papers, 2.3% of this breakdownSweden: 381 citing papers, 1.9% of this breakdown
0%21.2%Other 27.7%

Institutions

Fields

  • Medicine80.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Pharmacology, Toxicology and Pharmaceutics5.8%
  • Immunology and Microbiology1.3%
  • Nursing0.7%
  • Neuroscience0.6%
  • Other1.6%

Topics

  • Liver Disease Diagnosis and Treatment24.1%
  • Diet, Metabolism, and Disease6%
  • Liver Disease and Transplantation5.9%
  • Alcohol Consumption and Health Effects4.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.2%
  • Liver Diseases and Immunity2.6%
  • Other53.7%

Coauthors

All papers

Open in search
  1. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    Authors: Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi - Journal of Hepatology 2018 cited by 2,008

  2. The NAFLD fibrosis score

    Authors: Paul Angulo, Jason M. Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C. Farrell, Felicity Enders, Sushma Saksena, Alastair D. Burt, John P. Bida, Keith D. Lindor, Schuyler O. Sanderson, Marco Lenzi, Leon A. Adams, James G. Kench, Terry M. Therneau, Christopher P. Day - Hepatology 2007 cited by 3,200

  3. Steatohepatitis: A tale of two “hits”?

    Authors: Christopher P. Day, Oliver James - Gastroenterology 1998 cited by 4,287

  4. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

    Authors: Anna Mae Diehl, Christopher P. Day - New England Journal of Medicine 2017 cited by 1,307

  5. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    Authors: Stuart McPherson, Timothy Hardy, Jean‐François Dufour, Salvatore Petta, Manuel Romero‐Gómez, Mike Allison, Cláudia P. Oliveira, Sven Francque, Luc Van Gaal, Jörn M. Schattenberg, Dina Tiniakos, Alastair D. Burt, Elisabetta Bugianesi, Vlad Ratziu, Christopher P. Day, Quentin M. Anstee - The American Journal of Gastroenterology 2016 cited by 891

  6. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

    Authors: Quentin M. Anstee, Giovanni Targher, Christopher P. Day - Nature Reviews Gastroenterology & Hepatology 2013 cited by 1,753

  7. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Authors: Olivier Govaere, Simon Cockell, Dina Tiniakos, Rachel Queen, Ramy Younes, Michèle Vacca, Leigh Alexander, Federico Ravaioli, Jeremy M. Palmer, Salvatore Petta, Jérôme Boursier, Chiara Rosso, Katherine Johnson, Kristy Wonders, Christopher P. Day, Mattias Ekstedt, Matej Orešič, Rebecca Darlay, Heather J. Cordell, Fabio Marra, Antonio Vidal‐Puig, Pierre Bédossa, Jörn M. Schattenberg, Karine Clément, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Ann K. Daly, Quentin M. Anstee - Science Translational Medicine 2020 cited by 454

  8. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    Authors: Quentin M. Anstee, Rebecca Darlay, Simon Cockell, Marica Meroni, Olivier Govaere, Dina Tiniakos, Alastair D. Burt, Pierre Bédossa, Jeremy M. Palmer, Yang‐Lin Liu, Guruprasad P. Aithal, Michael Allison, Hannele Yki‐Järvinen, Michèle Vacca, Jean‐François Dufour, Pietro Invernizzi, Daniele Prati, Mattias Ekstedt, Stergios Kechagias, Sven Francque, Salvatore Petta, Elisabetta Bugianesi, Karine Clément, Vlad Ratziu, Jörn M. Schattenberg, Luca Valenti, Christopher P. Day, Heather J. Cordell, Ann K. Daly - Journal of Hepatology 2020 cited by 514

  9. Nonalcoholic fatty liver disease

    Authors: Elizabeth M. Brunt, Vincent Wai‐Sun Wong, Valério Nobili, Christopher P. Day, Silvia Sookoian, Jacquelyn J. Maher, Elisabetta Bugianesi, Claude B. Sirlin, Brent A. Neuschwander‐Tetri, Mary E. Rinella - Nature Reviews Disease Primers 2015 cited by 841

  10. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

    Authors: Giovanni Targher, Christopher P. Day, Enzo Bonora - New England Journal of Medicine 2010 cited by 1,904

  11. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    Authors: Ferenc E. Mózes, Jenny Lee, Yasaman Vali, Osama Alzoubi, Katharina Staufer, Michael Trauner, Rafael Paternostro, Rudolf Stauber, Adriaan G. Holleboom, Anne‐Marieke van Dijk, Anne Linde Mak, Jérôme Boursier, Marc Loup, Toshihide Shima, Elisabetta Bugianesi, Silvia Gaia, Angelo Armandi, Shalimar, Monica Lupșor‐Platon, Vincent Wai‐Sun Wong, Guanlin Li, Grace Lai‐Hung Wong, Jeremy Cobbold, Thomas Karlas, Johannes Wiegand, Giada Sebastiani, Emmanuel Tsochatzis, Antonio Liguori, Masato Yoneda, Atsushi Nakajima, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas and 130 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 187

  12. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

    Authors: Stuart McPherson, Timothy Hardy, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee - Journal of Hepatology 2014 cited by 1,049

  13. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

    Authors: Stuart McPherson, Stephen F Stewart, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day - Gut 2010 cited by 945

  14. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

    Authors: Timothy Hardy, Fiona Oakley, Quentin M. Anstee, Christopher P. Day - Annual Review of Pathology Mechanisms of Disease 2016 cited by 623

  15. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    Authors: Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton T. Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodríguez‐Cuenca, Maria Manuela Tonini, Tamara R. Castañeda, Aimo Kannt, Cecília M. P. Rodrigues, Simon Cockell, Olivier Govaere, Ann K. Daly, Michael Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne‐Christine Andréasson, Franklin Schlerman, Jonathon Marioneaux, Arun J. Sanyal, Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen and 138 more - Nature Metabolism 2024 cited by 229

  16. Prednisolone or Pentoxifylline for Alcoholic Hepatitis

    Authors: Mark R. Thursz, Paul Richardson, Michael Allison, Andrew Austin, Megan Bowers, Christopher P. Day, Nichola Downs, Dermot Gleeson, Alastair MacGilchrist, Allister Grant, Steven Hood, Steven Masson, Anne McCune, Jane Mellor, John O’Grady, David Patch, Ian Ratcliffe, Paul Roderick, Louise Stanton, Nikhil Vergis, Mark Wright, Stephen Ryder, Ewan H. Forrest - New England Journal of Medicine 2015 cited by 755

  17. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

    Authors: Liu Yl, Gillian Patman, Julian Leathart, A.-C. Piguet, Alastair D. Burt, Jean‐François Dufour, Christopher P. Day, Ann K. Daly, Helen L. Reeves, Quentin M. Anstee - Journal of Hepatology 2014 cited by 534

  18. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    Authors: Yang‐Lin Liu, Helen L. Reeves, Alastair D. Burt, Dina Tiniakos, Stuart McPherson, Julian Leathart, Michael Allison, Graeme Alexander, A.-C. Piguet, Rodolphe Anty, Peter T. Donaldson, Guruprasad P. Aithal, Sven Francque, Luc Van Gaal, Karine Clément, Vlad Ratziu, Jean‐François Dufour, Christopher P. Day, Ann K. Daly, Quentin M. Anstee - Nature Communications 2014 cited by 617

  19. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    Authors: Olivier Govaere, Sine Kragh Petersen, Nuria Martínez-López, Jasper Wouters, Matthias Van Haele, Rosellina Margherita Mancina, Oveis Jamialahmadi, Orsolya Bilkei‐Gorzo, Pierre Bel Lassen, Rebecca Darlay, Julien Peltier, Jeremy M. Palmer, Ramy Younes, Dina Tiniakos, Guruprasad P. Aithal, Michael Allison, Michèle Vacca, Melker Göransson, Rolando Berlinguer‐Palmini, James Clark, Michael Drinnan, Hannele Yki‐Järvinen, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Salvatore Petta, Elisabetta Bugianesi, Jörn M. Schattenberg, Christopher P. Day, Heather J. Cordell, Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 cited by 160

  20. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

    Authors: Kate Hallsworth, Gulnar Fattakhova, Kieren G. Hollingsworth, Christian Thoma, Sarah Moore, R. J. Taylor, Christopher P. Day, Michael I. Trenell - Gut 2011 cited by 515

  21. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review

    Authors: Christian Thoma, Christopher P. Day, Michael I. Trenell - Journal of Hepatology 2011 cited by 523

  22. Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

    Authors: Paul Angulo, Elisabetta Bugianesi, Einar S. Björnsson, Phunchai Charatcharoenwitthaya, Peter R. Mills, Francisco Barrera, Svanhildur Hafliðadóttir, Christopher P. Day, Jacob George - Gastroenterology 2013 cited by 507

  23. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†

    Authors: Luca Valenti, Ahmad Al‐Serri, Ann K. Daly, E. Galmozzi, Raffaela Rametta, Paola Dongiovanni, Valério Nobili, Enrico Mozzi, Giancarlo Roviaro, Ester Vanni, Elisabetta Bugianesi, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion, Christopher P. Day - Hepatology 2010 cited by 649

  24. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

    Authors: Indra Neil Guha, Julie Parkes, Paul Roderick, Dipanker Chattopadhyay, Richard Cross, Scott Harris, Philip Kaye, Alastair D. Burt, Steve D. Ryder, Guruprasad P. Aithal, Christopher P. Day, William Rosenberg - Hepatology 2007 cited by 740